5 November 2015

3 minute read

Europe

The practical approach to gathering antibiotic usage data on UK cattle farms was identified in a new review from the industry-led Cattle Health and Welfare Group of Great Britain (CHAWG).

The results were announced at a joint conference held by the Responsible Use of Medicines in Agriculture Alliance (RUMA) and the Veterinary Medicines Directorate (VMD).

The outcomes highlight the significant benefits better data could deliver, such as improving the way antibiotics are administered strategically to tackle disease.

But CHAWG’s chair Tim Brigstocke says it’s also important that the industry is able to accurately report usage levels because of the rising levels of antibiotic-resistant bacteria which threaten human health.

“We found that while data is already stored at every vet practice and in every farm medicine book, it currently exists in many different forms,” explained Mr Brigstocke.

“It’s also not collected or collated, and is further complicated by multi-species approvals for many of the antibiotics.

“This means we can’t always be sure in which type of animal a medicine has been used. For example, out of 420 tonnes of animal-authorised antibiotic active substance sold in the UK in 2013, only 14 tonnes was authorised solely for use in cattle.

"However, 63 tonnes was authorised for multi-species use in food producing animals and within the 217 products included in this, 201 are authorised for use in cattle.”

Room for improvement on data storage

Mr Brigstocke said that CHAWG will set up a working group to implement the report’s recommendations.

The starting point is likely to be the survey of vets carried out by the British Cattle Veterinary Association (BCVA), which formed part of the review. This suggested vets could be using as many as 15 different software programmes to log data, so CHAWG will be working with the BCVA and individual practices to look at how standard sets of data can be anonymised and exported.

“Then we will almost certainly look at how cattle farmers can be supported in migrating records from the physical ‘medicine book’ on the farm, into a spreadsheet or existing cattle management software for anonymous aggregation on a national level.

“There are undoubtedly areas where we can improve the effectiveness of how we use these powerful medicines to improve welfare.

"But the antibiotic resistance debate is an emotive one and we must also demonstrate accountability to ensure the preservation of antibiotics for future use in humans and animals; any future curbs on usage should be proportionate and informed, and not compromise animal wellbeing.”

Enhancing data collection ahead of possible regulation

Mandatory reporting in Europe could be just over the horizon and the European Medicines Agency has focused in the past year on developing a method for data collection on the usage of antibiotics in the EU pig sector.

In the UK, the VMD is encouraging the livestock sectors to develop systems appropriate to their own unique circumstances and industry characteristics.

“It’s therefore in cattle farmers’ own interests to anticipate the kind of figures it might be asked to supply in the future, and develop a way of collecting that data which suits the way the UK industry works,” said Mr Brigstocke.

“Then we can retain control over the data and the methodology, and ensure the reporting is accurate – and this in turn will help the VMD represent our case better in Europe as this debate continues.”

Throughout this project, CHAWG will be liaising with others – such as the pig sector – to ensure learnings are shared, duplication avoided and efficiencies realised where possible.

“We are very keen to listen to others who have expertise in this area,” Mr Brigstocke adds.

The CHAWG review report is available to download at www.chawg.org.uk.

TheCattleSite News Desk